ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï´Ù?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
±¸ºÐ | ºÐ·ù | Ç׸ñ | °¡°ÝÁ¤º¸ (´ÜÀ§ : ¿ø) | ƯÀÌ»çÇ× | ÃÖÁ¾º¯°æÀÏ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
¸íĪ | ÄÚµå | ±¸ºÐ | ºñ¿ë | ÃÖÀúºñ¿ë | ÃÖ´ëºñ¿ë | Ä¡·áÀç·á´ë Æ÷ÇÔ¿©ºÎ |
¾àÁ¦ºñ Æ÷ÇÔ¿©ºÎ |
||||
°Ë»ç·á | Ç÷Àå´Ü¹é°Ë»ç | Allergen specific IgE (others, CAP)(±¹¿ÜÀ§Å¹) | NPIS0003 | 37,730 | 2024-01-23 | ||||||
Ä¡°úóġ,¼ö¼ú·á | Ä¡¾ÆÁúȯ óġ | Amalgam Core | UZ001 | 20,000 | 2018-01-01 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | Androgen insensitivity syndrome | CZ663 | 724,900 | 2017-01-18 | ||||||
°Ë»ç·á | ÀÚ°¡¸é¿ªÁúȯ°Ë»ç | Anti IA-2 Ab(ICA 512 Ab)(±¹¿ÜÀ§Å¹) | NPIS0003 | 190,830 | 2023-09-26 | ||||||
°Ë»ç·á | °¨¿°Áõ Ç÷û°Ë»ç | Anti-EBV EA-DR, IgA (ºñ) | 20,900 | 2017-01-24 | |||||||
°Ë»ç·á | °¨¿°Áõ Ç÷û°Ë»ç | Anti-EBV VCA, IgA (ºñ) | 22,220 | 2017-01-06 | |||||||
°Ë»ç·á | ÀÚ°¡¸é¿ªÁúȯ°Ë»ç | Anti-GD1b, IgM isotype | CZ425 | 52,880 | 2017-01-01 | ||||||
°Ë»ç·á | °¨¿°Áõ Ç÷û°Ë»ç | Anti-Gliadin, IgA | NPIS0003 | 273,140 | 2023-01-07 | ||||||
°Ë»ç·á | °¨¿°Áõ Ç÷û°Ë»ç | Anti-Gliadin, IgG | NPIS0003 | 273,140 | 2023-01-07 | ||||||
°Ë»ç·á | ÀÚ°¡¸é¿ªÁúȯ°Ë»ç | Anti-NMO, IgG | CZ422 | 129,800 | 2017-01-01 | ||||||
°Ë»ç·á | ÀÚ°¡¸é¿ªÁúȯ°Ë»ç | Anti-heparin/PF4 (HIT-IgG Ab)(±¹¿ÜÀ§Å¹) | NPIS0003 | 102,180 | 2024-01-23 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | BRCA1 À¯ÀüÀÚ, ¿¢¼Õ°á½Ç/Áߺ¹(Hereditary breast and ovarian cancer) | CZ581 | 519,750 | 2023-04-18 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | BRCA2 À¯ÀüÀÚ, ¿¢¼Õ°á½Ç/Áߺ¹(Hereditary breast and ovarian cancer) | CZ581 | 519,750 | 2023-04-18 | ||||||
°Ë»ç·á | ÁöÁú, ¿µ¾ç °ü·Ã°Ë»ç | Beta-carotene | NPIS0003 | 299,550 | 2022-01-11 | ||||||
°Ë»ç·á | Ç÷¾×Çа˻ç | Blocking antibody test | 31,800 | 2017-04-24 |